Spots Global Cancer Trial Database for stage ivb cervical cancer

Every month we try and update this database with for stage ivb cervical cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer	NCT00601406	Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer	gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera...	-	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer	NCT00057863	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi...	Paclitaxel Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer	NCT01676818	Recurrent Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... Stage IVB Cervi...	eribulin mesyla...	18 Years -	University of Southern California
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00691301	Cervical Cancer	cisplatin pemetrexed diso...	- 120 Years	GOG Foundation
MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients	NCT00004936	Cervical Cancer	iodinated contr... computed tomogr... magnetic resona... gadopentetate d...	-	American College of Radiology Imaging Network
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer	NCT00287885	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer	docetaxel	18 Years -	Masonic Cancer Center, University of Minnesota
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer	NCT00002813	Cervical Cancer	cisplatin vinorelbine tar...	-	GOG Foundation
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00101192	Cervical Cancer	cetuximab cisplatin	18 Years -	GOG Foundation
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00101192	Cervical Cancer	cetuximab cisplatin	18 Years -	GOG Foundation
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Radiation Therapy in Treating Patients With Cervical Cancer	NCT00278304	Cervical Cancer	brachytherapy radiation thera...	18 Years -	National Cancer Institute (NCI)
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer	NCT00978874	Cervical Cancer	fludeoxyglucose... fluorine F 18 E...	18 Years - 120 Years	Abramson Cancer Center at Penn Medicine
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery	NCT01229930	Cervical Cancer	carboplatin cediranib malea... paclitaxel laboratory biom... pharmacological... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer	NCT03175848	Cervical Cancer...	Chemotherapy,ra...	18 Years - 70 Years	Zhejiang Cancer Hospital
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer	NCT00138151	Cervical Cancer	recombinant int... isotretinoin paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00016926	Cervical Cancer	capecitabine	-	GOG Foundation
Collecting Tumor Samples From Patients With Gynecological Tumors	NCT00897442	Borderline Ovar... Borderline Ovar... Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Childhood Embry... Childhood Malig... Endometrioid St... Gestational Tro... Malignant Mesot... Malignant Ovari... Melanoma Neoplasm of Unc... Ovarian Brenner... Ovarian Clear C... Ovarian Serous ... Paget Disease o... Recurrent Cervi... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... Stage I Ovarian... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Cervic... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage III Borde... Stage III Cervi... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Border... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Stage IVB Vulva... Uterine Corpus ... Uterine Corpus ... Vulvar Squamous...	Laboratory Biom...	-	GOG Foundation
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma	NCT00004261	Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma	EF5 flow cytometry fluorescent ant... immunohistochem... biopsy	18 Years - 120 Years	University Health Network, Toronto
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer	NCT01313104	Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	colposcopy cervical Papani... screening metho... screening metho...	18 Years -	Northwestern University
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer	NCT00019084	Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum...	18 Years -	National Cancer Institute (NCI)
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer	NCT00577317	Lymphedema Stage 0 Cervica... Stage 0 Uterine... Stage 0 Vulvar ... Stage I Uterine... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Uterin... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Uteri... Stage III Vulva... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Stage IVB Vulva...	Management of T... Management of T... Quality-of-Life...	18 Years -	GOG Foundation
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies	NCT00335998	Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIA Vulv... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIB Vulv... Stage IIIC Ovar... Stage IIIC Vulv... Stage IV Ovaria... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	triapine laboratory biom... external beam r... brachytherapy cisplatin pharmacological...	18 Years -	National Cancer Institute (NCI)
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer	NCT01313104	Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	colposcopy cervical Papani... screening metho... screening metho...	18 Years -	Northwestern University
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer	NCT00941070	Recurrent Cervi... Recurrent Vagin... Stage IB Cervic... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Therapy-related...	triapine cisplatin external beam r... quality-of-life... questionnaire a... fludeoxyglucose... positron emissi... computed tomogr...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer	NCT00057863	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi...	Paclitaxel Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Collecting Tumor Samples From Patients With Gynecological Tumors	NCT00897442	Borderline Ovar... Borderline Ovar... Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Childhood Embry... Childhood Malig... Endometrioid St... Gestational Tro... Malignant Mesot... Malignant Ovari... Melanoma Neoplasm of Unc... Ovarian Brenner... Ovarian Clear C... Ovarian Serous ... Paget Disease o... Recurrent Cervi... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... Stage I Ovarian... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Cervic... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage III Borde... Stage III Cervi... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Border... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Stage IVB Vulva... Uterine Corpus ... Uterine Corpus ... Vulvar Squamous...	Laboratory Biom...	-	GOG Foundation
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer	NCT00905658	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	therapeutic nut... standard follow...	18 Years - 65 Years	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer	NCT00601406	Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer	gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera...	-	National Cancer Institute (NCI)
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer	NCT00005941	Cervical Cancer Vaginal Cancer	therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera...	- 64 Years	Fred Hutchinson Cancer Center
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer	NCT00032162	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	carboplatin pegylated lipos...	18 Years -	AGO Study Group
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Immunotoxin Therapy in Treating Patients With Advanced Cancer	NCT00006981	Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton...	SS1(dsFv)-PE38 ...	18 Years -	National Cancer Institute (NCI)
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT01266447	Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi... Stage III Cervi... Stage IVA Cervi... Stage IVB Cervi...	Filgrastim Laboratory Biom... Pegfilgrastim Topotecan Hydro... Veliparib	18 Years -	National Cancer Institute (NCI)
Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00276796	Cervical Cancer	cisplatin paclitaxel topotecan hydro...	18 Years -	GOG Foundation
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer	NCT00807079	Cervical Cancer	carboplatin topotecan hydro...	18 Years -	ARCAGY/ GINECO GROUP
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00083213	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer	NCT04974944	Stage IVB Cervi... Recurrent Cervi... Persistent Cerv...	Camrelizumab Apatinib Paclitaxel Cisplatin Carboplatin Bevacizumab	18 Years - 70 Years	Sun Yat-sen University
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer	NCT00577317	Lymphedema Stage 0 Cervica... Stage 0 Uterine... Stage 0 Vulvar ... Stage I Uterine... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Uterin... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Uteri... Stage III Vulva... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Stage IVB Vulva...	Management of T... Management of T... Quality-of-Life...	18 Years -	GOG Foundation
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer	NCT01313104	Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin...	colposcopy cervical Papani... screening metho... screening metho...	18 Years -	Northwestern University
Radiation Therapy in Treating Patients With Cervical Cancer	NCT00278304	Cervical Cancer	brachytherapy radiation thera...	18 Years -	National Cancer Institute (NCI)
MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients	NCT00004936	Cervical Cancer	iodinated contr... computed tomogr... magnetic resona... gadopentetate d...	-	American College of Radiology Imaging Network
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer	NCT01098630	Recurrent Cervi... Recurrent Uteri... Recurrent Uteri... Stage I Uterine... Stage I Uterine... Stage IA Cervic... Stage IB Cervic... Stage II Uterin... Stage II Uterin... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Uteri... Stage III Uteri... Stage IV Uterin... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi...	Medical Chart R... Questionnaire A...	-	GOG Foundation
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.	NCT00258401	Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma	dietary interve... management of t... quality-of-life...	20 Years - 80 Years	Case Comprehensive Cancer Center
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.	NCT00258401	Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma	dietary interve... management of t... quality-of-life...	20 Years - 80 Years	Case Comprehensive Cancer Center
Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00276796	Cervical Cancer	cisplatin paclitaxel topotecan hydro...	18 Years -	GOG Foundation
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery	NCT01026792	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... Stage IVB Cervi...	Temsirolimus Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer	NCT00057928	Cervical Cancer	cisplatin gemcitabine hyd... paclitaxel	-	SWOG Cancer Research Network
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00691301	Cervical Cancer	cisplatin pemetrexed diso...	- 120 Years	GOG Foundation
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer	NCT00057928	Cervical Cancer	cisplatin gemcitabine hyd... paclitaxel	-	SWOG Cancer Research Network
Immunotoxin Therapy in Treating Patients With Advanced Cancer	NCT00006981	Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton...	SS1(dsFv)-PE38 ...	18 Years -	National Cancer Institute (NCI)
Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer	NCT00005999	Cervical Cancer	arsenic trioxid...	17 Years -	National Cancer Institute (NCI)
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix	NCT00064077	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVB Cervi...	Cisplatin Gemcitabine Hyd... Paclitaxel Quality-of-Life... Topotecan Hydro... Vinorelbine Tar...	18 Years -	GOG Foundation
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer	NCT00107445	Primary Periton... Stage I Endomet... Stage I Ovarian... Stage IA Cervic... Stage IB Cervic... Stage II Endome... Stage II Ovaria... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Endom... Stage III Ovari... Stage IV Endome... Stage IV Ovaria... Stage IVA Cervi... Stage IVB Cervi...	EF5	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer	NCT00003977	Cervical Cancer	human papilloma... in vitro-treate...	18 Years -	National Cancer Institute (NCI)
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer	NCT00905658	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	therapeutic nut... standard follow...	18 Years - 65 Years	National Cancer Institute (NCI)
Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix	NCT00006482	Cervical Cancer	cisplatin gemcitabine hyd...	-	GOG Foundation
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT00691301	Cervical Cancer	cisplatin pemetrexed diso...	- 120 Years	GOG Foundation
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer	NCT01676818	Recurrent Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... Stage IVB Cervi...	eribulin mesyla...	18 Years -	University of Southern California
Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix	NCT00030472	Cervical Cancer	pegylated lipos...	-	GOG Foundation
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma	NCT00004261	Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma	EF5 flow cytometry fluorescent ant... immunohistochem... biopsy	18 Years - 120 Years	University Health Network, Toronto
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners	NCT03112668	Malignant Femal... Malignant Hepat... Partner Stage III Breas... Stage III Cervi... Stage III Color... Stage III Lung ... Stage III Prost... Stage III Skin ... Stage III Uteri... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Skin... Stage IIIA Uter... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Skin... Stage IIIB Uter... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Skin... Stage IIIC Uter... Stage IV Breast... Stage IV Cervic... Stage IV Colore... Stage IV Lung C... Stage IV Prosta... Stage IV Skin M... Stage IV Uterin... Stage IVA Cervi... Stage IVA Color... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Color... Stage IVB Uteri...	Cognitive Behav... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer	NCT00383279	Cervical Cancer Ovarian Cancer Sarcoma	counseling inte... study of socioe...	18 Years - 120 Years	Wake Forest University Health Sciences
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix	NCT00005965	Cervical Cancer	bryostatin 1 cisplatin	18 Years -	National Cancer Institute (NCI)
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	NCT00030498	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Ependymob... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Primary H... Adult Subependy... Advanced Adult ... Advanced Malign... Male Breast Can... Recurrent Adeno... Recurrent Adult... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Malig... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage II Esopha... Stage II Pancre... Stage III Esoph... Stage III Pancr... Stage IIIB Non-... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Bladde... Stage IV Breast... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Unspecified Adu... Untreated Metas...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Radiation Therapy in Treating Patients With Cervical Cancer	NCT00278304	Cervical Cancer	brachytherapy radiation thera...	18 Years -	National Cancer Institute (NCI)
Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix	NCT00087113	Cervical Cancer	pemetrexed diso...	-	GOG Foundation
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	NCT00803062	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVB Cervi...	Bevacizumab Cisplatin Laboratory Biom... Paclitaxel Quality-of-Life... Questionnaire A... Topotecan Hydro...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: